Filter
4368
Text search:
new
medicines
Featured
Recommendations
468
New Publications
1170
Language
Document type
No document type
2238
Studies & Reports
764
Guidelines
624
Manuals
262
Strategic & Response Plan
216
Training Material
82
Fact sheets
78
Situation Updates
55
Infographics
17
Brochures
14
Resource Platforms
14
Online Courses
3
Videos
1
Countries / Regions
India
215
Global
206
Kenya
131
Uganda
109
South Africa
101
Ethiopia
92
Nepal
85
Sierra Leone
80
Liberia
79
Western and Central Europe
79
Africa
76
Nigeria
73
Tanzania
72
Myanmar / Burma
69
Zambia
67
Malawi
66
Latin America and the Carribbean
65
Bangladesh
63
Ghana
61
Ukraine
58
Rwanda
48
Namibia
47
Syria
43
Eastern Europe
34
Congo, Democratic Republic of
33
Philippines
33
South–East Asia Region
33
Zimbabwe
32
Asia
30
Venezuela
30
Mozambique
25
Haiti
24
Cambodia
22
Lesotho
22
Guinea
21
South Sudan
19
Indonesia
19
Yemen
19
East and Southern Africa
19
Burkina Faso
18
Senegal
18
West and Central Africa
18
Middle East and North Africa
17
Russia
17
Brazil
15
Botswana
15
Eastern Europe and Central Asia
15
Pakistan
13
Cameroon
12
Eswatini/ Swaziland
12
Madagascar
12
Sudan
11
North America
11
Afghanistan
10
Somalia
9
Thailand
9
Western Pacific Region
9
Germany
8
Lebanon
8
Colombia
8
Moldova
8
Vietnam
8
Central African Republic
7
Peru
7
Georgia
7
Jordan
6
China
6
Laos
6
Tajikistan
6
Mali
5
Iraq
5
Benin
5
North Macedonia
5
Bolivia
5
Paraguay
5
Poland
5
Palestine
5
Albania
5
Côte d’Ivoire / Ivory Coast
4
Hungary
4
Ecuador
4
El Salvador
4
Mexico
4
Bhutan
4
Southern Africa
4
Iran
4
United Kingdom
4
Morocco
3
Saudi Arabia
3
Niger
3
Egypt
3
Papua New Guinea
3
Argentina
3
Libya
3
Sri Lanka
3
Timor Leste/ East Timor
3
Romania
3
Jamaica
3
USA
2
Turkey
2
Chad
2
Gambia
2
Switzerland
2
Serbia
2
Honduras
2
Angola
2
Guatemala
2
Nicaragua
2
Chile
2
Canada
2
Qatar
2
Bulgaria
2
Kyrgyzstan
2
Australia
2
Gabon
2
Turkmenistan
2
Japan
2
Mauritius
2
Tunisia
2
Guinea-Bissau
1
Togo
1
Dominican Republic
1
Burundi
1
Greece
1
Other region
1
Fiji
1
Solomon Islands
1
Djibouti
1
Armenia
1
Mongolia
1
Congo-Brazzaville
1
Lithuania
1
Slovakia
1
Uzbekistan
1
Kazakhstan
1
Uruguay
1
Denmark
1
France
1
Maldives
1
Norway
1
Portugal
1
Spain
1
Belarus
1
Belize
1
Costa Rica
1
Panama
1
Authors & Publishers
Publication Years
Category
Countries
1725
Clinical Guidelines
401
Public Health
257
Women & Child Health
191
Key Resources
160
Capacity Building
86
Pharmacy & Technologies
54
Annual Report MEDBOX
2
Toolboxes
HIV
383
COVID-19
307
TB
290
Mental Health
268
AMR
242
Pharmacy
173
NTDs
121
NCDs
121
Caregiver
114
Conflict
106
Disability
91
Ebola & Marburg
87
Malaria
85
Planetary Health
81
Global Health Education
69
Rapid Response
60
Refugee
60
Health Financing Toolbox
58
Natural Hazards
44
2.0 Rapid Response
25
Zika
16
Cholera
14
Polio
11
Specific Hazards
10
Social Ethics
6
Typhoon
1
Pharmacy Toolbox
recommended
Please find all relevant guidelines and information in our new Pharmacy Toolbox.
The PHARMACY TOOLBOX is a comprehensive knowledge repository to provide its users with practical, up-to-date information on
...
This guide provides national stakeholders and advocates with information and guidance to update the national essential medicines list to include a new commodity, a
...
7 June 2022. To treat complications associated with measles: severe complications with module 1 (50 cases) and mild complications with module 8 (20 cases).
The new measles kit 2021 is designed to prepare for and support the treatment of non-severe
...
It is estimated that around 2 billion people worldwide do not have access to essential medicines. Access to medicines in the Eastern Mediterranean Region varies among countries, depending on their i
...
The report provides a brief introduction to patents and licences and their effect on the market for antiretroviral (ARV) medicines. It gives an overview of the patent landscape with respect to a select number of ARV
...
How to address the global crisis in antibiotic research and development.
The report includes a comprehensive summary and critical evaluation of recent initiatives to overcome the barriers to achieve sustainable access to antibiotics. As antibiotic resistance will continue to develop as long as we
...
Globally each year, millions of people suffer illness or lose their lives because the vaccines, medicines and diagnostic tests that they need are either unavailable or unaffordable – and this lack of access to medicine is acute in low- and middle-
...
9 June 2021
Since its launch, GLASS has expanded in scope and coverage and as of May 2021, 109 countries and territories worldwide have enrolled in GLASS. A key new component in GLASS is the inclusion of antimicrobial consumption (AMC) surveillance
...
Healthy communities rely on well-functioning ecosystems. They provide clean air, fresh water, medicines and food security. They also limit disease and stabilize the climate. But biodiversity loss is happening at unprecedented rates, impacting human
...
Antimicrobial resistance has become one of the most eminent threats to global health and a rising concern for healthcare specialists. All around the world, many common infections are becoming resistant to the antimicrobial medicines used to treat th
...
Cardiovascular diseases (CVD) represent the highest burden of disease globally. Medicines are a critical intervention used to prevent and treat CVD. This review describes access to medication for CVD from a health system perspective and strategies t
...
This policy brief has been developed in response to the contemporary challenge of antibiotic resistance (ABR). ABR poses a formidable threat to global health and sustainable development. It is now increasingly recognized that the systematic neglect of cultural factors is one of the biggest obs
...
Community pharmacists are the health professionals most accessible to the public and are a cornerstone of primary health care. The role of community pharmacists is expanding globally. This report provides an overview of existing components and provisions of the legal and regulatory framework for com
...
The World Heart Federation (WHF) Roadmap series covers a large range of cardiovascular conditions. These Roadmaps identify potential roadblocks and their solutions to improve the prevention, detection and management of cardiovascular diseases and provide a generic global framework available for loca
...
Antimicrobial resistance (AMR) is occurring everywhere in the world, compromising the ability to treat infectious diseases, as well as undermining many other advances in health and medicine. Underlying factors that drive AMR include; weak or absent surveillance and monitoring systems, inadequate sys
...
Nearly 90 years after Simon Kuznets first introduced Gross Domestic Product (GDP) for the limited purpose of measuring economic growth (by measuring the monetary value of all local goods and services within a given period of time), calls continue to mount for decision-makers to stop using GDP and it
...
Hendra virus (HeV) continues to pose a serious public health concern as spillover events occur sporadically. Terminally ill horses can exhibit a range of clinical signs including frothy nasal discharge, ataxia or forebrain signs. Early signs, if detected, can include depression, inappetence, colic o
...
Antimicrobial resistance (AMR) is a global human, animal, plant and environment health threat that needs to be addressed by every country. The impacts of AMR are wide-ranging in terms of human health, animal health, food security and safety, environmental effects on ecosystems and biodiversity, and
...
After 100 years of chemotherapy with impractical and toxic drugs, an oral cure for human African trypanosomiasis (HAT) is available: Fexinidazole. In this case, we review the history of drug discovery for HAT with special emphasis on the discovery, pre-clinical development, and operational challenge
...
